What Does the Environment Have to Do with Medicine? Reporting Back from a Premier Reproductive Society Conference

October 28, 2009
2:00 pm US Eastern Time

Slides & Resources

Resources Discussed on the Call

  • The Endocrine Disruption Exchange's Critical Windows of Development tool: Go to http://www.endocrinedisruption.org and under What's New, click on Critical Windows. You can also listen to the CHE Partnership Call that highlighted how to use the tool.
  • A description of the Endocrine Disruption Prevention Act of 2009 (Download). For more information, please contact TEDX.
  • Toxic Matters brochure. A brochure that highlights how to prevent exposure to toxic substances at home, in the workplace and in your community. Produced by the Program on Reproductive Health and the Environment (PRHE) at the University of California, San Francisco.
  • Safer Chemicals, Healthy Families. A coalition of diverse groups united by their common concern about toxic chemicals in our homes, places of work, and products we use every day, focusing on reform of the federal Toxic Substances Control Act (TSCA).
  • Join the next CHE Partnership Call, Navigating the Scientific Evidence to Ensure Prevention, focused on a key meeting that took place in August 2009 to translate the emerging science in environmental reproductive health into timely action in clinical and policy arenas.

Listen to Recording

The CHE-Fertility and Reproductive Health Working Group hosted a discussion that highlighted the role of the Environment and Special Interest Group (ERSIG) at the American Society for Reproductive Medicine (ASRM), a premier reproductive society. ERSIG was established in 2007, and has since then promoted an environmental focus within ASRM. The mission of ERSIG is to enhance understanding of environmental factors on reproductive health through excellence in education, research and clinical practice.

We heard reports from the following ASRM members on environmental health highlights from this year's ASRM conference, which took place in Atlanta, Georgia, October 17-21, 2009:

  • Andrew R. La Barbera, PhD, HCLD, Scientific Director, American Society for Reproductive Medicine, Adjunct Professor of Obstetrics and Gynecology, University of Alabama Birmingham School of Medicine, Professor Emeritus of Obstetrics and Gynecology, University of Cincinnati College of Medicine
  • Susan Benoff, PhD, Associate Professor of Obstetrics & Gynecology and of Cell Biology and Director, Fertility Research Laboratories, New York University School of Medicine; and Chair-Elect of ERSIG
  • Michael Diamond, MD, Kamran S. Moghissi Professor and Associate Chair of Obstetrics and Gynecology, Director, Division of Reproductive Endocrinology and Infertility, Assistant Dean for Clinical and Translational Research, Wayne State University School of Medicine, and Director, Detroit Regional Institute for Clinical and Translational Research; and Secretary of ERSIG
  • Kevin Osteen, PhD, Professor, Department of Obstetrics & Gynecology, Vanderbilt University School of Medicine; and ERSIG Treasurer

Steve Heilig, MPH, Director of Public Health and Education, San Francisco Medical Society and CHE, moderated this call.